237 related articles for article (PubMed ID: 9693264)
1. The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases.
Valenta R; Almo S; Ball T; Dolecek C; Steinberger P; Laffer S; Eibensteiner P; Flicker S; Vrtala S; Spitzauer S; Valent P; Denepoux S; Kraft D; Banchereau J; Lebecque S
Int Arch Allergy Immunol; 1998 Jul; 116(3):167-76. PubMed ID: 9693264
[TBL] [Abstract][Full Text] [Related]
2. Renaissance of the blocking antibody concept in type I allergy.
Flicker S; Valenta R
Int Arch Allergy Immunol; 2003 Sep; 132(1):13-24. PubMed ID: 14555854
[TBL] [Abstract][Full Text] [Related]
3. Immunological and structural similarities among allergens: prerequisite for a specific and component-based therapy of allergy.
Valenta R; Steinberger P; Duchêne M; Kraft D
Immunol Cell Biol; 1996 Apr; 74(2):187-94. PubMed ID: 8724008
[TBL] [Abstract][Full Text] [Related]
4. Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
Tulaeva I; Kratzer B; Campana R; Curin M; van Hage M; Karsonova A; Riabova K; Karaulov A; Khaitov M; Pickl WF; Valenta R
Front Immunol; 2020; 11():1368. PubMed ID: 32733455
[TBL] [Abstract][Full Text] [Related]
5. Allergen structures and epitopes.
Meno KH
Allergy; 2011 Jul; 66 Suppl 95():19-21. PubMed ID: 21668845
[TBL] [Abstract][Full Text] [Related]
6. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.
Focke M; Mahler V; Ball T; Sperr WR; Majlesi Y; Valent P; Kraft D; Valenta R
FASEB J; 2001 Sep; 15(11):2042-4. PubMed ID: 11511525
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of IgE-binding allergen epitopes.
Lollier V; Denery-Papini S; Brossard C; Tessier D
Clin Immunol; 2014 Jul; 153(1):31-9. PubMed ID: 24680999
[TBL] [Abstract][Full Text] [Related]
8. Recombinant allergy vaccines based on allergen-derived B cell epitopes.
Valenta R; Campana R; Niederberger V
Immunol Lett; 2017 Sep; 189():19-26. PubMed ID: 28472641
[TBL] [Abstract][Full Text] [Related]
9. An in vitro model for the allergen-IgE-FcARI interaction.
Laffer S; Hogbom E; Adrianson J; Grönlund H; Sillaber C; Valent P; Vangelista L; Kricek F; Kraft D; Valenta R
Int Arch Allergy Immunol; 1999; 118(2-4):116-8. PubMed ID: 10224355
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
Valenta R; Vrtala S; Focke-Tejkl M; Bugajska-Schretter ; Ball T; Twardosz A; Spitzauer S; Grönlund H; Kraft D
Biol Chem; 1999; 380(7-8):815-24. PubMed ID: 10494830
[TBL] [Abstract][Full Text] [Related]
11. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future.
Valenta R; Campana R; Focke-Tejkl M; Niederberger V
J Allergy Clin Immunol; 2016 Feb; 137(2):351-7. PubMed ID: 26853127
[TBL] [Abstract][Full Text] [Related]
12. [New concepts in therapy of type I allergic diseases].
Valenta R; Steinberger P; Vrtala S; Grote M; Laffer S; Sperr WR; Valent P; Kraft D; Scheiner O
Wien Klin Wochenschr; 1993; 105(23):682-6. PubMed ID: 7508663
[TBL] [Abstract][Full Text] [Related]
13. High-affinity IgG to a major A. fumigatus allergen, Asp f 2, retards allergic response.
Svirshchevskaya EV; Viskova N; Shevchenko M; Alekseeva L; Marchenko A; Benevolensky S; Kurup VP
Med Sci Monit; 2004 Oct; 10(10):BR371-80. PubMed ID: 15448590
[TBL] [Abstract][Full Text] [Related]
14. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
Gieras A; Cejka P; Blatt K; Focke-Tejkl M; Linhart B; Flicker S; Stoecklinger A; Marth K; Drescher A; Thalhamer J; Valent P; Majdic O; Valenta R
J Immunol; 2011 May; 186(9):5333-44. PubMed ID: 21451110
[TBL] [Abstract][Full Text] [Related]
15. The role of immunoglobulin E-binding epitopes in the characterization of food allergy.
Lin J; Sampson HA
Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):357-63. PubMed ID: 19568005
[TBL] [Abstract][Full Text] [Related]
16. From allergen genes to allergy vaccines.
Valenta R; Ferreira F; Focke-Tejkl M; Linhart B; Niederberger V; Swoboda I; Vrtala S
Annu Rev Immunol; 2010; 28():211-41. PubMed ID: 20192803
[TBL] [Abstract][Full Text] [Related]
17. Molecular Aspects of Allergens and Allergy.
Valenta R; Karaulov A; Niederberger V; Gattinger P; van Hage M; Flicker S; Linhart B; Campana R; Focke-Tejkl M; Curin M; Eckl-Dorna J; Lupinek C; Resch-Marat Y; Vrtala S; Mittermann I; Garib V; Khaitov M; Valent P; Pickl WF
Adv Immunol; 2018; 138():195-256. PubMed ID: 29731005
[TBL] [Abstract][Full Text] [Related]
18. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.
van Neerven RJ; Knol EF; Ejrnaes A; Würtzen PA
Int Arch Allergy Immunol; 2006; 141(2):119-29. PubMed ID: 16864979
[TBL] [Abstract][Full Text] [Related]
19. The application of phage display in allergy research: characterization of IgE, identification of allergens and development of novel therapeutics.
Edwards MR; Collins AM; Ward RL
Curr Pharm Biotechnol; 2001 Sep; 2(3):225-40. PubMed ID: 11530877
[TBL] [Abstract][Full Text] [Related]
20. A single mouse monoclonal antibody, E58 modulates multiple IgE epitopes on group 1 cedar pollen allergens.
Goldblum RM; Ning B; Judy BM; Holthauzen LM; van Bavel J; Kamijo A; Midoro-Horiuti T
Mol Immunol; 2016 Jun; 74():106-12. PubMed ID: 27174188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
